Brainstorm Cell Therapeutics Inc. (BCLI)

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $9.65 million. The enterprise value is $9.78 million.

Market Cap	9.65M
Enterprise Value	9.78M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

BCLI has 7.91 million shares outstanding. The number of shares has increased by 65.60% in one year.

Current Share Class	7.91M
Shares Outstanding	7.91M
Shares Change (YoY)	+65.60%
Shares Change (QoQ)	+11.11%
Owned by Insiders (%)	10.59%
Owned by Institutions (%)	4.20%
Float	6.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.21

Current Ratio	0.21
Quick Ratio	0.16
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-159.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-222.36%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	167.91%
Revenue Per Employee	n/a
Profits Per Employee	-$410,593
Employee Count	27
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.37% in the last 52 weeks. The beta is 0.21, so BCLI's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	-81.37%
50-Day Moving Average	1.11
200-Day Moving Average	1.99
Relative Strength Index (RSI)	55.91
Average Volume (20 Days)	3,435,135

Short Selling Information

The latest short interest is 209,504, so 2.65% of the outstanding shares have been sold short.

Short Interest	209,504
Short Previous Month	291,418
Short % of Shares Out	2.65%
Short % of Float	3.35%
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-12.31M
Pretax Income	-15.53M
Net Income	-11.09M
EBITDA	-12.07M
EBIT	-12.31M
Earnings Per Share (EPS)	-$2.01

Balance Sheet

The company has $1.64 million in cash and $1.77 million in debt, giving a net cash position of -$126,000 or -$0.02 per share.

Cash & Cash Equivalents	1.64M
Total Debt	1.77M
Net Cash	-126,000
Net Cash Per Share	-$0.02
Equity (Book Value)	-7.46M
Book Value Per Share	-0.94
Working Capital	-8.57M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.60%
Shareholder Yield	-65.60%
Earnings Yield	-114.86%
FCF Yield	n/a

Analyst Forecast

The average price target for BCLI is $30.00, which is 2,359.02% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	2,359.02%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Oct 1, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1